Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chinmay Das

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
3 Biotech|January 8, 2026
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cellsChinmay Das, Subarno Paul, Subhasmita Bhal, et al.
RSC Medicinal Chemistry|March 22, 2024
Molecular editing of <b>NSC-666719</b> enabling discovery of benzodithiazinedioxide-guanidines as anticancer agentsVajja Krishna Rao, Subarno Paul, Mitchell Gulkis, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
3 Biotech|January 8, 2026
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cellsChinmay Das, Subarno Paul, Subhasmita Bhal, et al.
RSC Medicinal Chemistry|March 22, 2024
Molecular editing of <b>NSC-666719</b> enabling discovery of benzodithiazinedioxide-guanidines as anticancer agentsVajja Krishna Rao, Subarno Paul, Mitchell Gulkis, et al.
Pageof 4